The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Recent Advances in Arsenic Carcinogenesis: Modes of Action, Animal Model Systems, and Methylated Arsenic Metabolites
Abstract
Recent advances in our knowledge of arsenic carcinogenesis include the development of rat or mouse models for all human organs in which inorganic arsenic is known to cause cancer-skin, lung, urinary bladder, liver, and kidney. Tumors can be produced from either promotion of carcinogenesis protocols (mouse skin and lungs, rat bladder, kidney, liver, and thyroid) or from complete carcinogenesis protocols (rat bladder and mouse lung). Experiments with p53(+/-) and K6/ODC transgenic mice administered dimethylarsinic acid or arsenite have shown some degree of carcinogenic, cocarcinogenic, or promotional activity in skin or bladder. At present, with the possible exception of skin, the arsenic carcinogenesis models in wild-type animals are more highly developed than in transgenic mice. Recent advances in arsenic metabolism have suggested that methylation of inorganic arsenic may be a toxification, rather than a detoxification, pathway and that trivalent methylated arsenic metabolites, particularly monomethylarsonous acid and dimethylarsinous acid, have a great deal of biological activity. Accumulating evidence indicates that these trivalent, methylated, and relatively less ionizable arsenic metabolites may be unusually capable of interacting with cellular targets such as proteins and even DNA. In risk assessment of environmental arsenic, it is important to know and to utilize both the mode of carcinogenic action and the shape of the dose-response curve at low environmental arsenic concentrations. Although much progress has been recently made in the area of arsenic's possible mode(s) of carcinogenic action, a scientific concensus has not yet been reached. In this review, nine different possible modes of action of arsenic carcinogenesis are presented and discussed-induced chromosomal abnormalities, oxidative stress, altered DNA repair, altered DNA methylation patterns, altered growth factors, enhanced cell proliferation, promotion/progression, gene amplification, and suppression of p53.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Monomethylarsonous Acid (MMAIII) Is More Toxic Than Arsenite in Chang Human Hepatocytes
Petrick, J. S., Ayala-Fierro, F., Cullen, W. R., Carter, D. E., & Vasken Aposhian, H. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8872 · Cited by 716
Arsenic: health effects, mechanisms of actions, and research issues.
Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B., Fowler, B., Goyer, R., Menzer, R., Rossman, T., Thompson, C., et al. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107593 · Cited by 657
Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P., & Waalkes, M. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10907 · Cited by 559
Reviews in biochemical toxicology
Ecobichon, D. J. (1979) · Pesticide Biochemistry and Physiology · doi:10.1016/0048-3575(79)90115-9 · Cited by 506
O'Brien, T. G. (1976) · PubMed · Cited by 437
Tanaka, K., Miura, N., Satokata, I., Miyamoto, I., Yoshida, M. C., Satoh, Y., Kondo, S., Yasui, A., Okayama, H., & Okada, Y. (1990) · Nature · doi:10.1038/348073a0 · Cited by 388
Brien, T. G. (1976) · Cited by 354
Speciation of Key Arsenic Metabolic Intermediates in Human Urine
Le, X. C., Lu, X., Ma, M., Cullen, W. R., Aposhian, H. V., & Zheng, B. (2000) · Analytical Chemistry · doi:10.1021/ac000527u · Cited by 332
Mass, M. J., & Wang, L. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00008-2 · Cited by 309
Cited by
Arsenic: toxicity, oxidative stress and human disease
Jomova, K., Jenisova, Z., Feszterova, M., Baros, S., Liska, J., Hudecova, D., Rhodes, C. J., & Valko, M. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1649 · Cited by 1,431
Arsenic Exposure and Toxicology: A Historical Perspective
Hughes, M. F., Beck, B. D., Chen, Y., Lewis, A. S., & Thomas, D. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr184 · Cited by 1,312
Aquatic arsenic: Toxicity, speciation, transformations, and remediation
Sharma, V. K., & Sohn, M. (2009) · Environment International · doi:10.1016/j.envint.2009.01.005 · Cited by 1,119
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Heavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Human Health Effects From Chronic Arsenic Poisoning–A Review
KAPAJ, S., PETERSON, H., LIBER, K., & BHATTACHARYA, P. (2006) · Journal of Environmental Science and Health, Part A · doi:10.1080/10934520600873571 · Cited by 937
Arsenic-induced oxidative stress and its reversibility
Flora, S. J. S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.008 · Cited by 824
The Cellular Metabolism and Systemic Toxicity of Arsenic
Thomas, D. J., Styblo, M., & Lin, S. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9258 · Cited by 592
Arsenic geochemistry and health
DUKER, A., CARRANZA, E., & HALE, M. (2005) · Environment International · doi:10.1016/j.envint.2004.10.020 · Cited by 585
In Situ Imaging of Metals in Cells and Tissues
McRae, R., Bagchi, P., Sumalekshmy, S., & Fahrni, C. J. (2009) · Chemical Reviews · doi:10.1021/cr900223a · Cited by 570
Mechanism of arsenic carcinogenesis: an integrated approach
Rossman, T. G. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.07.009 · Cited by 559
A Quantitative Systems Approach Reveals Dynamic Control of tRNA Modifications during Cellular Stress
Chan, C. T. Y., Dyavaiah, M., DeMott, M. S., Taghizadeh, K., Dedon, P. C., & Begley, T. J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001247 · Cited by 465
Arsenic Exposure and the Induction of Human Cancers
Martinez, V. D., Vucic, E. A., Becker-Santos, D. D., Gil, L., & Lam, W. L. (2011) · Journal of Toxicology · doi:10.1155/2011/431287 · Cited by 438
Tchounwou, P. B., Patlolla, A. K., & Centeno, J. A. (2003) · Toxicologic Pathology · doi:10.1080/01926230390242007 · Cited by 411
The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update.
Stýblo, M., Drobná, Z., Jaspers, I., Lin, S., & Thomas, D. J. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.110-1241242 · Cited by 389
Arsenic toxicity, mutagenesis, and carcinogenesis – a health risk assessment and management approach
Tchounwou, P. B., Centeno, J. A., & Patlolla, A. K. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007260.32981.b9 · Cited by 374
Cohen, S. M., Arnold, L. L., Eldan, M., Lewis, A. S., & Beck, B. D. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440500534230 · Cited by 372
Effects Of Arsenic Exposure On Dna Methylation And Epigenetic Gene Regulation
Reichard, J. F., & Puga, A. (2010) · Epigenomics · doi:10.2217/epi.09.45 · Cited by 362
Arsenic and Cardiovascular Disease
States, J. C., Srivastava, S., Chen, Y., & Barchowsky, A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn236 · Cited by 350
Waalkes, M. P., Ward, J. M., Liu, J., & Diwan, B. A. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00022-4 · Cited by 343
Arsenic in the aetiology of cancer
Tapio, S., & Grosche, B. (2006) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.02.001 · Cited by 334
Elemental and Chemically Specific X-ray Fluorescence Imaging of Biological Systems
Pushie, M. J., Pickering, I. J., Korbas, M., Hackett, M. J., & George, G. N. (2014) · Chemical Reviews · doi:10.1021/cr4007297 · Cited by 332
The Vascular System as a Target of Metal Toxicity
Prozialeck, W. C., Edwards, J. R., Nebert, D. W., Woods, J. M., Barchowsky, A., & Atchison, W. D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm263 · Cited by 329
Arsenic carcinogenesis in the skin
Yu, H.-S., Liao, W.-T., & Chai, C.-Y. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9092-8 · Cited by 318
Metabolism, toxicity and anticancer activities of arsenic compounds
Khairul, I., Wang, Q. Q., Jiang, Y. H., Wang, C., & Naranmandura, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14733 · Cited by 300
The potential biological mechanisms of arsenic-induced diabetes mellitus
Tseng, C.-H. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.02.009 · Cited by 296
Oxidative stress as a possible mode of action for arsenic carcinogenesis
Kitchin, K. T., & Ahmad, S. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00376-4 · Cited by 291
Self-citationMolecular mechanisms of arsenic carcinogenesis
Huang, C., Ke, Q., Costa, M., & Shi, X. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000007261.04684.78 · Cited by 288
Biomarkers of Exposure: A Case Study with Inorganic Arsenic
Hughes, M. F. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9058 · Cited by 285
Tseng, C.-H., Huang, Y.-K., Huang, Y.-L., Chung, C.-J., Yang, M.-H., Chen, C.-J., & Hsueh, Y.-M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.11.022 · Cited by 277
Seafood arsenic: Implications for human risk assessment
Borak, J., & Hosgood, H. D. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.09.005 · Cited by 268
Davey, J. C., Bodwell, J. E., Gosse, J. A., & Hamilton, J. W. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm013 · Cited by 266
Biological Gradient Between Long-Term Arsenic Exposure and Carotid Atherosclerosis
Wang, C.-H., Jeng, J.-S., Yip, P.-K., Chen, C.-L., Hsu, L.-I., Hsueh, Y.-M., Chiou, H.-Y., Wu, M.-M., & Chen, C.-J. (2002) · Circulation · doi:10.1161/01.cir.0000015862.64816.b2 · Cited by 262
Epigenetics and the Environment
SUTHERLAND, J. E., & COSTA, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05970.x · Cited by 261
Arsenic–selenium and mercury–selenium bonds in biology
GAILER, J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.07.018 · Cited by 180
Zhang, T.-C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg141 · Cited by 142
Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells
Sciandrello, G. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh029 · Cited by 130
Review: Biological methylation of less-studied elements
Thayer, J. S. (2002) · Applied Organometallic Chemistry · doi:10.1002/aoc.375 · Cited by 112
Gentry, P. R., McDonald, T. B., Sullivan, D. E., Shipp, A. M., Yager, J. W., & Clewell, H. J. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20505 · Cited by 89
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Metadata
- Authors
- Kitchin, K. T.
- Venue
- Toxicology and Applied Pharmacology
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 172
- Issue
- 3
- Pages
- 249-261
- ISSN
- 0041-008X (ISSN-L)
- OpenAlex
- W2035029439
- Cited by
- 792
- References
- 57
- FWCI
- 39.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.